Telesis Bio INC Form 4 insider transactions

Director Todd Krueger acquired 8,390 restricted stock units and options to purchase 5,268 shares of Telesis Bio Inc. common stock on July 24, 2024.

Director Steven J. Golub acquired 8,390 shares of common stock and 5,268 stock options in Telesis Bio Inc. on July 24, 2024.

Director Sarah E. Hlavinka reports acquisition of Telesis Bio Inc. stock and options on July 24, 2024.

Director Michael R. Hodges acquired shares and options in Telesis Bio Inc. on July 24, 2024, through restricted stock units (RSUs) and stock options.

Director James B. Weissman acquired 8,390 shares of common stock and 5,268 stock options in Telesis Bio Inc. on July 24, 2024.

Director Frank Witney reports acquisition and disposal of Telesis Bio Inc. stock and stock options.

Annette Tumolo, a director at Telesis Bio Inc., reports the acquisition of restricted stock units and stock options.

Director Christine Tsingos reports acquisition of restricted stock units and stock options in Telesis Bio Inc.

Director Jami Nachtsheim reports the acquisition of restricted stock units and stock options in Telesis Bio Inc.

Director Gregory J. Herrema of Telesis Bio Inc. reports acquisition of restricted stock units and stock options.

Eric Eugene Esser, President & CEO of Telesis Bio Inc., reports acquisition of stock options and restricted stock units.

CEO Todd Robert Nelson reports transactions involving Telesis Bio Inc. stock, including acquisition of restricted stock units and shares withheld for tax obligations.

Eric Esser, President & COO of Telesis Bio Inc., reports acquisition of restricted stock units and stock options, as well as shares withheld for tax obligations.

Chief Technology Officer Daniel Glenn Gibson of Telesis Bio Inc. reports acquisition of restricted stock units and stock options, as well as shares withheld for tax obligations.

Chief Legal Officer Rob Cutler reports acquisition of restricted stock units and stock options, as well as shares withheld for tax obligations.

Telesis Bio Inc.'s CEO, Nelson Todd Robert, reports changes in beneficial ownership of company stock due to tax withholding and vesting of Restricted Stock Units.

Chief Technology Officer of Telesis Bio Inc., Daniel Glenn Gibson, reports a transaction involving the withholding of shares to cover tax obligations related to vested Restricted Stock Units.

Chief Legal Officer Rob Cutler reports disposition of shares to cover tax obligations related to vesting Restricted Stock Units.